Liquid plasma
It is an improved substance for the use in our daily life easily by dissolution of plasma into the water. It can be used for prevention and treatments of various diseases without irritation, so it pays attention as a next generation therapy.
01 Targeted sterilization
* Applicable businesses: general cosmetics, functional cosmetics, consumer chemical products, quasi-drugs, and drugs
* Certified institute: Korea Testing & Research Institute (KTR)
* Test institution: College of Veterinary Medicine, Jeonbuk National University
[Patent application]
10-2020-0153027
02 Relieve inflammation (acne, atopic dermatitis)
* Applicable businesses: functional cosmetics, quasi-drugs, and drugs
[thesis]
Liquid-type nonthermal atmospheric plasma enhanced regenerative potential of silk-fibrin composite gel in radiation-induced wound failure.
Non-thermal plasma inhibits mast cell activation and ameliorates allergic skin infammatory diseases in NC/Nga mice.
Non-thermal plasma treated solution with potential as a novel therapeutic agent for nasal mucosa regeneration.
Opposite effects of non-thermal plasma on cell migration and collagen production in keloid and normal fibroblasts.
Non-Thermal Plasma Induces Antileukemic Effect Through mTOR Ubiquitination.
Non-thermal plasma induces AKT degradation through turn-on the MUL1 E3 ligase in head and neck cancer. Nonthermal plasma induces apoptosis in ATC cells: Involvement of JNK and p38 MAPK-dependent ROS.
[Patent application]
10-2017-0100291
10-2017-0102295
10-2017-0110764
10-2017-0110760
10-2017-0119293
10-2018-0111159
10-2020-0153027
10-2019-0083818
10-2019-0083817
PCT/KR2017/010234
PCT/KR2017/010235
PCT/KR2018/009700
PCT/KR2018/0010941
16/464,180
16/643,418
16/648,087
16/335,904
16/335,925
14/982,948
[patent registration]
10-1979105
10-2035458
10-2062320
10-1933920
10-2120552
10537014
03 Tissue regeneration
* Applicable businesses: quasi-drugs and drugs
[thesis]
Liquid-type nonthermal atmospheric plasma enhanced regenerative potential of silk-fibrin composite gel in radiation-induced wound failure.
Liquid-type non-thermal atmospheric plasma ameliorates vocal fold scarring by modulating vocal fold fibroblast.
Non-thermal plasma inhibits mast cell activation and ameliorates allergic skin infammatory diseases in NC/Nga mice.
Nonthermal atmospheric plasma enhances myoblast differentiation by eliciting STAT3 phosphorylation.
Non-thermal plasma treated solution with potential as a novel therapeutic agent for nasal mucosa regeneration.
Opposite effects of non-thermal plasma on cell migration and collagen production in keloid and normal fibroblasts.
[Patent application]
10-2017-0100291
10-2017-0110764
10-2017-0110761
10-2021-0108363
PCT/KR2017/010235
PCT/KR2017/012771
PCT/KR2018/009700
16/643,418
16/335,904
10-1979105
10-2035458
10-2062320
10-1933920
10-2120552
10537014
[patent registration]
10-2035458
10-2006784
04 Wound healing
* Applicable businesses: : quasi-drugs, drugs, and medical devices
[thesis]
Liquid-type nonthermal atmospheric plasma enhanced regenerative potential of silk-fibrin composite gel in radiation-induced wound failure.
Liquid-type non-thermal atmospheric plasma ameliorates vocal fold scarring by modulating vocal fold fibroblast.
Opposite effects of non-thermal plasma on cell migration and collagen production in keloid and normal fibroblasts.
[Patent application]
10-2017-0110764
10-2017-0110761
10-2021-0108363
10-2020-0153027
PCT/KR2017/010235
PCT/KR2017/012771
PCT/KR2018/009700
16/643,418
[patent registration]
10-2006784
05 Anticancer
* Applicable businesses: medical devices
[thesis]
HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer.
Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling.
Non-thermal plasma induces AKT degradation through turn-on the MUL1 E3 ligase in head and neck cancer.
Nonthermal plasma induces apoptosis in ATC cells: Involvement of JNK and p38 MAPK-dependent ROS.
Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G(1) arrest via the ATM/p53 pathway.
Non-Thermal Atmospheric Pressure Plasma Inhibits Thyroid Papillary Cancer Cell Invasion via Cytoskeletal Modulation, Altered MMP-2/-9/uPA Activity.
[Patent application]
10-2020-0153027
10-2015-0153582
14/982,948
[patent registration]
10-1657063
9750951